










568Revista Científica da Ordem dos Médicos          www.actamedicaportuguesa.com                                                                                                                
RESUMO
Introdução: O programa de Enhanced Recovery After Surgery® consiste na implementação de várias medidas perioperatórias que re-
duzem o stress cirúrgico e, consequentemente melhoram a recuperação dos doentes. O objetivo deste estudo é avaliar a compliance 
com o programa Enhanced Recovery After Surgery® bem como os resultados obtidos no final do primeiro ano da sua implementação 
para a cirurgia colorretal eletiva no nosso hospital.
Material e Métodos: Foi feita uma análise dos 210 doentes submetidos a cirurgia colorretal no período entre maio de 2016 e dezem-
bro de 2017. O grupo de doentes intervencionados após a implementação do protocolo (grupo Enhanced Recovery After Surgery®) 
foi comparado com um grupo que recebeu cuidados convencionais (grupo pré- Enhanced Recovery After Surgery®). Diferenças entre 
os dois grupos foram ajustadas usando o emparelhamento com base na propensão. Os objetivos primários foram o tempo de inter-
namento, o tempo até retorno do trânsito intestinal, a incidência de complicações e a mortalidade. Analisámos também a evolução da 
compliance com as recomendações Enhanced Recovery After Surgery®.
Resultados: Após emparelhamento com base na propensão para pertencer ao grupo pré- Enhanced Recovery After Surgery® e 
Enhanced Recovery After Surgery®, foram incluídos 112 doentes neste estudo, 56 em cada grupo. A adesão global ao protocolo 
Enhanced Recovery After Surgery® registou um aumento de 35,7% para 80,8%. Houve uma redução no tempo de internamento, tempo 
até retorno do trânsito intestinal e complicações médicas.
Discussão: O programa Enhanced Recovery After Surgery® é seguro e parece reduzir a estadia hospital e melhorar a recuperação 
dos doentes.
Conclusão: Este estudo mostrou que a implementação do programa Enhanced Recovery After Surgery®  foi possível no Hospital 
Beatriz Ângelo e teve um impacto positivo no pós-operatório imediato dos doentes com patologia colorretal. 
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ABSTRACT
Introduction: The Enhanced Recovery After Surgery® program comprises the implementation of various perioperative measures that 
reduce surgical stress and ultimately improve patient recovery and outcome. The purpose of this study is to evaluate the first-year 
compliance and clinical outcomes after implementation of the Enhanced Recovery After Surgery® program in elective colorectal surgery 
in our hospital.
Material and Methods: An analysis was performed on the 210 patients who underwent elective colorectal surgery from May 2016 to 
December 2017. The group of patients that underwent surgery after the protocol implementation (Enhanced Recovery After Surgery® 
group) was compared to a conventional care control group (pre- Enhanced Recovery After Surgery® group). Differences between the 
two groups were adjusted using Propensity Score matching. The main outcomes were length of stay, return of bowel function, complica-
tions and mortality. The evolution of compliance with Enhanced Recovery After Surgery® principles was also analyzed.
Results: After propensity score matching, 112 patients were included in the present study: 56 patients formed the pre-Enhanced Re-
covery After Surgery® group and 56 the Enhanced Recovery After Surgery® group. The overall adherence to the protocol increased from 
35.7% to 80.8%. There was a decrease in length of stay, time to return of bowel function and medical complications.
Discussion: The Enhanced Recovery After Surgery® program is safe and seems to shorten length of stay and improve patient recovery 
and clinical outcome.
Conclusion: This study showed that the implementation of the Enhanced Recovery After Surgery® program was possible in Hospital 
Beatriz Ângelo, with a positive impact in the immediate postoperative recovery of colorectal patients.
Keywords: Colon/surgery; Digestive System Surgical Procedures; Elective Surgical Procedures; Perioperative Care; Portugal; Rec-
tum/surgery
INTRODUCTION
 The Enhanced Recovery After Surgery (ERAS®) pro-
gram is an evidence-based multidisciplinary care pathway, 
which entails a change in the perioperative management 
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protocols. The goal of the program is to reduce the surgical-
induced neuroendocrine stress response, by treating the 
potential risk factors, in order to shorten length of hospital 
stay, perioperative morbidity and mortality. 
 It was developed by a group of European surgeons, who 
founded the ERAS® Study Group in 2001, which was the 
basis of the ERAS® Society, created in 2010. This new ap-
proach to the surgical patient contrasts with the ‘fast track’ 
concept, which emerged for the first time in 1994, since it 
emphasizes the quality of the care given and not solely fast 
discharge.1
 The first ERAS® protocols were drafted in the early 
2000s, initially for colon surgery and swiftly followed by rec-
tal surgery. After this, a wide range of surgical areas fol-
lowed the same path.
 The ERAS® Society guidelines for Colorectal Surgery 
were last updated in 2018. They encompass 24 core ele-
ments (Table 1) that include preoperative, intraoperative 
and postoperative measures to be implemented.2
 Several studies have shown that the application of these 
protocols is safe, leads to a better postoperative recovery, a 
faster return of bowel function, less morbidity and a shorter 
length of hospital stay after surgery.2-4
 The implementation of these protocols is a complex pro-
cess which requires the integration and contribution of all 
the professional groups involved, including surgeons, an-
esthesiologists, nurses, nutritionists and physiotherapists, 
among others. 
 Constant monitoring is needed to guarantee sustain-
ability and continuous improvement. In the absence of con-
tinuous training and auditing there is a decrease in the pro-
gram’s compliance.5 It has been shown that a compliance 
greater than 70% is associated with better clinical results,6-8 
including 5-year survival after malignant colorectal surgery.
 Hospital Beatriz Ângelo was the first hospital in Portugal 
to adhere to the ERAS® society program. The ERAS® im-
plementation program (EIP) consists of four seminars and 
three action periods in between, with a total length of eight to 
10 months. It started with the creation of a multidisciplinary 
team composed of surgeons, anesthesiologists, nurses, an 
intensive care physician and a member of the management 
board. During this period, this team had weekly meetings 
where international guidelines were adapted to the local 
features, the patient perioperative circuit was organized, 
patients´ data were introduced in the audit system and staff 
education was prepared.
 One of the important steps was the reorganization of the 
preoperative period with the creation of new appointments 
in order to better evaluate and optimize the surgical patient. 
These included nursing, nutritional and physical rehabilita-
tion consultations, in addition to the preexisting general sur-
gery and anesthesiology ones. They form a one-day bundle 
to avoid extra visits to the hospital and enable patient edu-
cation and management of their expectations. It also allows 
for the formulation, together with the patient, of a postopera-
tive recovery plan including early mobilization, ambulation 
and oral intake.
 Another crucial change in perioperative care was to 
grant dedicated time to an ERAS® nurse for patient and 
family support, supervision of the circuit, data collection and 
audit, and staff coaching.
 As said before, maintaining this program is not possible 
without continuous auditing of the compliance with the dif-
ferent protocol´s elements and the clinical outcomes. This 
allows the team to identify the success of the implementa-
tion or the need of change in strategy. To enable this, the 
patients’ clinical data have to be inserted in EIAS (ERAS® 
interactive audit system) in real time.
 Hospital Beatriz Ângelo (HBA) in Loures, Portugal, start-
ed the ERAS® implementation program (EIP) for colorectal 
Table 1  –  Recommendations for perioperative care in colon and rectal surgery1
Preoperative Intraoperative Postoperative
Patient education and counselling Minimal invasive surgical techniques No nasogastric tubes
Cessation of smoking and excessive 
intake of alcohol Avoid long-acting opioids Early removal of urinary catheter
Medical optimization of chronic disease Mid-thoracic epidural for open surgery Avoidance of salt and water overload
Preoperative nutritional assessment and, 
as needed, nutritional support Avoidance of salt and water overload
Early intake oral fluids and solids/
nutritional supplements
No prolonged fasting and carbohydrate 
loading Maintenance of normothermia Multimodal non-opioid oral analgesia
No/selective bowel preparation Prevention of nausea and vomiting Early mobilization
Antibiotic prophylaxis No drains Stimulation of gut mobility
Thromboprophylaxis Audit of compliance and outcomes
No premedication
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surgery in May 2016, which lasted about 8 months; and 
since January 2017 all colorectal surgery patients were in-
cluded in the program. The purpose of this study is to evalu-
ate the first-year compliance and clinical outcomes.
MATERIALS AND METHODS
Patients
 A consecutive series of 210 patients undergoing elec-
tive colorectal surgery in Hospital Beatriz Ângelo was ana-
lyzed. The first 67 patients (pre-ERAS® group) underwent 
surgery in 2016 and were registered during the implementa-
tion program. The remaining 143 are all the patients treated 
during 2017 – after the full implementation of the ERAS® 
program (ERAS® group). The data concerning both groups 
of patients (which include over one hundred variables) were 
inserted into the ERAS® database (EIAS – ERAS® interac-
tive audit system), either retrospectively (pre-ERAS® group) 
or prospectively (ERAS® group). The study was approved 
by the Health Ethics Committee of Hospital Beatriz Ângelo.
Outcomes
 Demographics and preoperative data of all patients 
were extracted from the EIAS database: gender, age, body 
mass index (BMI), history of tobacco use, diabetes, car-
diovascular and respiratory disease, American Society of 
Anesthesiologists (ASA) physical status, P-POSSUM score 
mortality risk, use of neoadjuvant treatment, final diagno-
sis and procedure group (colonic vs rectal). The operative 
variables analyzed were duration of surgery, intraoperative 
blood loss, total volume of IV fluids and transfusion rate.
 Compliance with the care elements of the periopera-
tive period was recorded and compared between the two 
groups. The compliance represents the percentage of pa-
tients that were treated according to the protocol and it is 
calculated taking into account only the data available (the 
data not registered in the clinical records appear as ‘miss-
ing’).
 The main outcome measures in the postoperative pe-
riod were length of stay (number of days between operation 
and discharge), time to return of bowel function (described 
as time to first flatus and first bowel movement), complica-
tions (divided in medical and surgical and according to their 
severity – Clavien-Dindo classification) and mortality.
Carrão A, et al. Results from elective colorectal surgery after one year of implementation of ERAS®, Acta Med Port 2020 Sep;33(9):568-575 




(n = 56) p-value
Gender - n (%) 0.321
          Female 17 (30.4%) 22 (39.3%)
          Male 39 (69.6%) 34 (60.7%)
Age, years – median (Q1 - Q3) 72 (61.0 - 77.0) 72.5 (57.5 - 80.5) 0.524
Body Mass Index, kg/m2 - median (Q1 - Q3)1 26 (23.6 - 29.7) 26.7 (24.3 - 28.9) 0.511
Tobacco use – n (%)2 3 (5.7%) 3 (5.4%) 0.381
Comorbidities – n (%)
          Cardiovascular disease3 1 (1.8%) 1 (1.8%) 0.752
          Respiratory disease4 3 (5.4%) 1 (1.8%) 0.309
          Diabetes 19 (33.9%) 20 (35.7%) 0.843
ASA performance score – n (%) 1.000
          I 1 (1.8%) 1 (1.8%)
          II 37 (66.1%) 37 (66.1%)
          III 18 (32.1%) 18 (32.1%)
          IV
P-POSSUM mortality risk, % - median (Q1 - Q3) 3.3 (1.6 - 7.7) 2.85 (1.9 - 6.8) 0.738
Diagnosis – n (%) 0.586
          Malign 47 (84.0%) 46 (82.2%)
          Benign 9 (16.0%) 10 (17.8%)
Surgical procedure group – n (%) 0.825
          Colon 43 (76.8%) 42 (75.0%)
          Rectal 13 (23.2%) 14 (25.0%)
Neoadjuvant chemotherapy – n (%) 9 (16.1%) 6 (10.7%) 0.405
Neoadjuvant radiotherapy – n (%) 7 (12.5%) 5 (8.9%) 0.541
* Seven missing-values in the pre-ERAS group and one in the ERAS group; **Three missing-values in the pre-ERAS group 
Analysis of categorical variables was done using the χ2 test except for ‘Cardiovascular disease’ and ‘Respiratory disease’ which used Fisher’s exact test. Analysis of continuous vari-
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Statistical analysis
 Statistical analysis was performed using SPSS software 
version 23 for Windows (SPSS Inc., Chicago, IL, USA). 
Descriptive data were reported as mean ± standard devi-
ation (SD), median (interquartile range - IQR) or number 
of patients (percentage) as appropriate. Categorical vari-
ables were compared using the Pearson’s chi-square test 
or Fisher’s exact test. For continuous variables, differences 
between groups were tested using Student’s t test for nor-
mally distributed data or the Mann-Whitney U test for non-
normally distributed data (based on Kolmogorov-Smirnov 
test). A p-value < 0.05 was considered statistically signifi-
cant.
 In order to reduce selection bias, pre and ERAS® pa-
tients were matched according to propensity scores de-
termined with the near neighbor matching procedure. 
Diabetes, respiratory disease and ASA score were used 




 Demographic patient data and preoperative character-
istics are shown in Table 2. After propensity score match-
ing, one hundred and twelve patients were included in the 
present study: 56 patients formed the pre-ERAS® group and 
56 the ERAS® group. There was no difference in median 
age, BMI or in the distribution of gender between the two 
groups. Also, there was no significant difference regarding 
history of tobacco use, cardiovascular disease, respiratory 
disease, diabetes, ASA score and mortality risk prediction 
P-POSSUM score. Finally, there was no difference regard-
ing the surgical procedure group (colonic vs rectal), the di-
agnosis (whether it was benign or malignant) nor whether 
the patient had received neoadjuvant chemotherapy or ra-
diotherapy.
Perioperative variables
 Regarding the preoperative period (Table 3), there was 
a significant increase in patient education and counselling 
(0% vs 100%, p-value < 0.001), fluid and carbohydrate 
loading (63.6% vs 96.4%, p-value < 0.001) and thrombo-
prophylaxis (92.6% vs 100%, p-value < 0.001). The use of 
sedative premedication decreased (55.6% vs 5.4%, p-value 
<0.001) as did bowel preparation (50% vs 28.6%, p-value 
0.021). 
 The intraoperative variables for the ERAS® and pre-
ERAS® groups are presented in Table 4. The difference 
in mean duration of surgery did not achieve statistical sig-
nificance (216.9 minutes vs 190.4 minutes, p-value 0.166) 
but there was a significant reduction in the median amount 
of fluids administered in the intraoperative period (1316.9 
mL vs 1796.5 mL, p-value 0.039). Despite this reduction in 
fluid therapy, the need for vasoactive medication was not 
increased (p-value 0.611). There was no statistically signifi-
cant difference regarding blood loss and transfusion rate. 
Monitoring of anesthesia depth and maintenance of nor-
mothermia increased (p-value < 0.001) whereas the use of 
opioid analgesia (p-value < 0.001) and surgical drains de-
creased (p-value 0.033). The use of nerve blocks and local 
anesthesia also increased (21.7% vs 51%, p-value 0.004) 
and there wasn´t a statistically significant difference in the 
use of mid-thoracic epidural anesthesia in open surgery. 
Regarding the prevention of nausea and vomiting there was 
not a significant difference either (98.2% vs 100%, p-value 
0.495).
 During the postoperative period there was a significant 
decrease in the median duration of intravenous fluid thera-
py in the ERAS® group (four days versus one day, p-value 
< 0.001) as well as an increase in the median volume of 
oral fluids on the day of surgery (0 mL vs 700 mL, p-value 
< 0.001), as shown in Table 5. This group also had a sta-
tistically significant increase in stimulation of gut mobility, 
avoidance of nasogastric tubes as well as earlier removal 
of urinary catheter (p-value < 0.001). About three quarters 
(73.2%) of the patients in the ERAS® group had early mobi-
lization (out of bed in the day of surgery and walking three 
times a day starting in the first postoperative day), when 
compared with 14.8% in the pre-ERAS® group (p-value < 
0.001). The use of opioids for postoperative analgesia had 
a major decrease in the ERAS® group (3.6% vs 38.9%, p-
value < 0.001).
Compliance
 Overall mean adherence to the ERAS® protocol was 
80.8% in the ERAS® group compared with 35.7% in the pre-
ERAS® group (p-value < 0.001). The compliance in each 
operative period is described in Table 6.




(n = 56) p-value
Patient education and counselling (including nutrition assessment) – n (%) 0 (0.0%) 56 (100.0%) < 0.001
Fluid and carbohydrate loading – n (%)2 35 (63.6%) 54 (96.4%) < 0.001
Bowel preparation – n (%)3 27 (50.0%) 16 (28.6%) 0.021
Antibiotic prophylaxis – n (%)4 53 (96.4%) 56 (100.0%) 0.243
Thromboprophylaxis – n (%)5 50 (92.6%) 56 (100.0%) < 0.001
Sedative premedication – n (%)6 30 (55.6%) 3 (5.4%) < 0.001
1 According to the ERAS® Society Guidelines: World J Surg. 2019;43:659-95.2
2,4 One missing-value in the pre-ERAS group; 3,5,6 Two missing-values in the pre-ERAS group
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Outcomes
 Time to return of bowel function
 Overall there was a faster return of bowel function in 
the ERAS® group compared with the pre-ERAS® group. The 
median time to first flatus decreased from two to one day (p-
value 0.004) while the median time to first bowel movement 
decreased from three to two days (p-value 0.001). Patients 
also started solid oral intake earlier in the postoperative pe-
riod in the ERAS® group (p-value < 0.001).
 Complications and Reoperations
 There was no difference in the overall number of pa-
tients who presented complications (p-value 0.154) as sum-
marized in Table 7. In the pre-ERAS® group, 37.5% (22) of 
the patients developed at least one complication compared 
with 25% (14) in the ERAS® group. In both groups 28.6% 
of these were major complications. When analyzing over-
all medical complications, there was a significant decrease 
in the ERAS® group (14.3% vs 39.3%, p-value 0.003). 
There was no difference regarding surgical complications. 




(n = 56) p-value
Duration of surgery, minutes – mean ± SD2 216.9 ± 109.4 190.4 ± 89.7 0.166
Total fluid volume, mL – mean ± SD3 1796.5 ± 1197.4 1316.9 ± 884.3 0.039
Vasoactive medication – n (%)4 13 (29.5%) 14 (25.0%) 0.611
Blood loss, mL – median (Q1 - Q3)5 100 (50 - 200) 100 (50 - 200) 0.477
Transfusion rate, mL – mean ± SD6 116.67 ± 531.9 6.25 ± 35.8 0.171
Monitoring of anesthesia depth – n (%)7 13 (52.0%) 55 (8.2%) < 0.001
No opioid analgesia – n (%)8 29 (60.4%) 56 (100.0%) < 0.001
Mid-thoracic epidural anaesthesia in open surgery – n (%) 9 (64.3%) 8 (47.1%) 0.276
Nerve blocks or local anesthesia – n (%)9 12 (21.7%) 28 (51.0%) 0.004
Maintenance of normothermia – n (%)10 23 (74.2%) 51 (100.0%) < 0.001
Prevention of nausea and vomiting – n (%) 54 (98.2%) 56 (100.0%) 0.495
No surgical drains – n (%) 29 (51.8%) 40 (71.4%) 0.033
1 According to the ERAS® Society Guidelines: World J Surg. 2019;43:659-95.2
2,5,11 One missing-value in the pre-ERAS group; 3 27 missing-values in the pre-ERAS group; 4 12 missing-values in the pre-ERAS group; 6 11 missing-values in the pre-ERAS group; 
7 31 missing-values in the pre-ERAS group; 8 Eight missing-values in the pre-ERAS group; 9 One missing-value in the pre-ERAS group and one in the ERAS group; 10 25 missing-values 
in the pre-ERAS group and five in the ERAS group
Analysis of categorical variables was done using the χ2 test except for ‘Monitoring of anaesthesia depth’, ‘Maintenance of normothermia’ and ‘Prevention of nausea and vomiting’ which 
used Fisher’s exact test. Analysis of continuous variables was done using Student’s t-test except for ‘Blood loss’ which used the Mann-Whitney U test.




(n = 56) p-value
Oral fluids on day of surgery, mL – median (Q1 - Q3)2 0 (0 - 0) 700 (325 - 1000) < 0.001
IV fluids on day of surgery, mL – median (Q1 - Q3)3 2000 (1250 - 2550) 2000 (1587.5 - 2450) 0.386
Duration of IV fluid therapy, days – median (Q1 - Q3)4 4 (3 - 6) 1 (1 - 2) < 0.001
Stimulation of gut mobility* – n (%) 11 (19.6%) 39 (69.6%) < 0.001
No nasogastric tubes – n (%) 17 (30.9%) 52 (92.9%) < 0.001
Time to removal of urinary catheter, days – median (Q1 - Q3)5 2 (1 - 3) 1 (1 - 1) < 0.001
Early mobilization – n (%)6 8 (14.8%) 41 (73.2%) < 0.001
Opioid analgesia – n (%)7 21 (38.9%) 2 (3.6%) < 0.001
1 According to the ERAS® Society Guidelines: World J Surg. 2019;43:659-95.2
2 25 missing-values in the pre-ERAS group; 3 19 missing-values in the pre-ERAS group; 4 Four missing-values in the pre-ERAS group and one in the ERAS group; 5 Three missing-
values in the pre-ERAS group and four in the ERAS group; 6,7 Two missing-values in the pre-ERAS group
Analysis of categorical variables was done using the χ2 test. Analysis of continuous variables was done using the Mann-Whitney U test.
* Laxatives, chewing gum or both; IV: intravenous




(n = 56) p-value
Overall compliance, % - mean ± SD 35.7 ± 8.7 80.8 ± 12.9 < 0.001
       Preoperative compliance, % - mean ± SD 58.8 ± 18.1 96.3 ± 6.8 < 0.001
       Intraoperative compliance, % - mean ± SD 46.3 ± 26.1 86.3 ± 16.4 < 0.001
       Postoperative compliance, % - mean ± SD 18.4 ± 9.7 69.1 ± 22.3 < 0.001












Revista Científica da Ordem dos Médicos          www.actamedicaportuguesa.com                                                                                                                573
Carrão A, et al. Results from elective colorectal surgery after one year of implementation of ERAS®, Acta Med Port 2020 Sep;33(9):568-575 




(n = 56) p-value
Length of stay, days
          Overall – median (Q1 - Q3) 6 (4.0 - 10.7) 4 (4.0 - 7.0) < 0.001
          Colon procedures – median (Q1 - Q3) 6 (5.0 - 9.0) 4 (3.0 - 6.0) < 0.001
          Rectal procedures – mean ± SD 12.3 ± 6.9 7.1 ± 3.6 0.028
ICU admission – n (%) 4 (7.1%) 1 (1.8%) 0.182
Time to first flatus, days – median (Q1 - Q3)1 2 (1 - 3) 1 (1 - 2) 0.004
Time to first bowel movement, days – median (Q1 - Q3)2 3 (2 - 4) 2 (1 - 3) 0.001
Time to solid oral intake, days – median (Q1 - Q3) 4 (3 - 5) 1 (1 - 2) < 0.001
Patients with complications – n (%) 21 (37.5%) 14 (25%) 0.154
Complication severity grade* – n (%) 0.652
          Minor 15 (71.4%) 10 (71.4%)
          Major 6 (28.6%) 4 (28.6%)
Medical complications – n (%) 22 (39.3%) 8 (14.3%) 0.003
Surgical complications – n (%) 10 (17.9%) 8 (14.3%) 0.607
Reoperations – n (%) 6 (10.7%) 4 (7.1%) 0.508
Readmissions – n (%) 4 (7.1%) 3 (5.4%) 0.500
Deaths – n (%) 0 (0.0%) 0 (0.0%) -
1 22 missing-values in the pre-ERAS group and nine in the ERAS group; 2 One missing-values in the pre-ERAS group and three in the ERAS-group
* Minor complication: Clavien-Dindo I, II and IIIa; Major complication: Clavien-Dindo > IIIa
Analysis of categorical variables was done using the χ2 test except for ‘ICU admission’, ‘Complication severity grade’ and ‘Readmissions’ which used Fisher’s exact test. Analysis of 
continuous variables was done using the Mann-Whitney U test except for ‘Length of stay – Rectal procedures’ which used Student’s t-test.
ICU: intensive care unit
There was no difference in the number of patients receiving 
unplanned operation after primary surgery nor in the num-
ber of readmissions after discharge.
 Length of Stay (LOS)
 There was a significant decrease in the length of stay 
from a pre-ERAS® median of six days to an ERAS® median 
of four days (p-value < 0.001) as depicted in Table 7. In the 
ERAS® groups, patients undergoing colonic surgery spent a 
median of four days in hospital while those who underwent 
rectal surgery spent on average 7.1 days. Around 7% (n = 
4) of the patients in the pre-ERAS® group versus 1.8% (n = 
1) in the ERAS® group required admission to the Intensive 
Care Unit (p-value 0.182). 
 Mortality
 There were no deaths in both groups.
Discussion
 In our hospital, the overall adherence to the protocol in-
creased from 35.7% to 80.8%, which is in accordance with 
various published studies and accomplishes the threshold 
associated with better clinical outcomes.6-8
 In contrast to traditional care, 100% of the ERAS® pa-
tients attended preoperative education and counseling. 
There was a statistically significant rise in the percentage of 
patients receiving the carbohydrate loading supplement on 
the evening before and morning of the surgery. This prac-
tice complies with ASA Practice Guidelines for Preoperative 
Fasting.9 According to some authors this also decreases the 
perioperative catabolic process and insulin resistance10-12 
and, ultimately, increases patient satisfaction.13
 Although still in debate, the ERAS® Society does not 
recommend bowel preparation as a routine, since it is linked 
to adverse effects such as dehydration, prolonged ileus and 
patient distress without any evidence of advantages.14-16 
This strategy was included in our hospital’s protocol and 
there was a statistically significant decrease in its use (50% 
vs 28.6%, p-value 0.021).
 Regarding the intraoperative period, restrictive fluid 
therapy is an established practice that is believed to reduce 
the incidence of several complications, including anastomo-
sis leak, fluid overload and hypothermia.17-20 This practice 
was adopted and there was a decrease in average intra-
operative fluid therapy from 1796.5ml to 1316.9ml. This 
change occurred without an increase in use of vasoactive 
medication, which may indicate that the patients arrive at 
the operating room well hydrated. 
 The ERAS® program emphasizes pain control through 
the use of a multimodal opioid-sparing analgesic scheme. 
Our protocol established performing a thoracic epidural 
block for laparotomic surgery. For laparoscopic surgeries or 
if contraindications for a thoracic epidural block were pre-
sent, other regional techniques (including intrathecal opi-
oids) or IV lidocaine perfusion were instituted. In addition 
to this, postoperative analgesia is switched to oral at post-
operative day one. Based on this analgesic scheme, the 
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100%. At the same time, the use of peripheral nerve blocks 
or local anesthesia increased from 21.7% to 51%. 
 According to the ERAS® Society peritoneal drainage 
hasn´t shown any advantage in the available literature2 and 
may impair patient postoperative mobilization. The avoid-
ance of surgical drain placement was promoted and there 
was a decrease in its use from 49.2% to 28.6%.
 The routine prophylactic use of nasogastric intubation is 
being abandoned. An association has been shown between 
its use and postoperative fever, oropharyngeal and pulmo-
nary complications.21 There was a significant difference in 
the use of nasogastric intubation before and after the imple-
mentation of the program, with a decrease from 69.1% to 
7.1%.
 In order to reduce the infectious risk, patient discomfort 
and facilitate mobilization, an early removal of urinary cath-
eter was promoted with a reduction in the median of time to 
remove it from two days to one day.2
 The ERAS® patients’ postoperative period is marked by 
early mobilization and ambulation (73.2% of the patients), 
which in our case reflects the effort and coordination be-
tween the ERAS® nurse and the ward and rehabilitation 
nurses. 
 These patients also had a faster onset of oral fluid intake 
and progression to solid food. There was an increase in the 
average oral fluid intake in the day of the surgery from 0 to 
700 mL and a decrease in the average duration of intrave-
nous fluid therapy from four to one day. All patients were of-
fered a liquid diet and supplements on the day of surgery and 
progress to solid food at the postoperative day one.
 This early advancement of diet and prompt mobilization 
may have contributed to the quicker return of bowel func-
tion observed (median decreased from three to two days), 
which in turn may have been associated with the shorter 
length of stay.
 The return of gastrointestinal function was assessed us-
ing the time to first flatus and time to first bowel movement. 
In these fields, an improvement was observed with reduc-
tion of the median time of at least one day. This may be 
associated with the use of measures that promote bowel 
motility, such as administration of domperidone, reduction 
of the use of opioid analgesics, early mobilization and am-
bulation. 
 Similar to other existing studies,6,7,22-24 there was a statis-
tically significant decrease in the rate of medical but not of 
surgical complications. 
 Regarding length of stay, there was a significant de-
crease in hospitalization time from a median of 6 to 4 days 
for all elective colorectal patients. This shorter length of stay 
was not associated with a higher percentage of readmis-
sions, which reflects the safety of this program. This allows 
not only to lower the cost per patient, increase patient turno-
ver and hospital productivity (a growing concern in the cur-
rent era of cost-containment in health care),24-26 but also a 
faster return to usual patient activity and improvement in 
patient satisfaction.26,27
Limitations
 Despite the good results obtained, this study presents 
some limitations. These include the retrospective nature 
of the pre-ERAS® group and small sample size (further re-
duced by the need to perform a propensity score matching 
due to differences in patient characteristics such as ASA 
score (III), higher incidence of respiratory disease and dia-
betes). Another limitation is the lack of registration of sev-
eral parameters before the implementation of the protocol.
CONCLUSION
 This study showed that the implementation of ERAS® 
program in Hospital Beatriz Ângelo was possible, with a 
positive impact on outcomes. It´s execution is a complex 
process that requires a multidisciplinary approach, a struc-
tured implementation program and continuous data audit. It 
requires the commitment of the patient and all the periop-
erative professionals and represents a change in the institu-
tion culture.
 As in other studies, it was shown that enhanced re-
covery programs are safe and bring major benefits to the 
patients. Its adoption is spreading worldwide, and this evi-
dence based multimodal approach is becoming the corner-
stone of high-quality perioperative care.
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